Nutricel Additive Solution – AS-3 (Haemonetics Manufacturing Inc.)


Welcome to the PulseAid listing for the Nutricel Additive Solution – AS-3 drug offered from Haemonetics Manufacturing Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Haemonetics Manufacturing Inc.
NON-PROPRIETARY NAME: CP2D/AS-3 Anticoagulant and Additive System
SUBSTANCE NAME: DEXTROSE; ADENINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-09-13
END MARKETING DATE: 0000-00-00


Nutricel Additive Solution – AS-3 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNutricel Additive Solution – AS-3 from Haemonetics Manufacturing Inc.
LABELER NAME: Haemonetics Manufacturing Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.21; .033(g/110mL; g/110mL)
START MARKETING DATE: 2013-09-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53157-101_25edc224-0331-45f2-842d-cc2b9514a9da
PRODUCT NDC: 53157-101
APPLICATION NUMBER: BN820915

Other DEXTROSE; ADENINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Haemonetics Manufacturing IncLeukotrap – AS-3 Solution
Haemonetics Manufacturing Inc.Nutricel Additive Solution – AS-3